Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Aug 21;20(10):592. doi: 10.1038/s41577-020-00439-1

Attacking the defence: SARS-CoV-2 can infect immune cells

Mariana Borsa 1,, Julie M Mazet 1,
PMCID: PMC7441839  PMID: 32826975

Lymphopenia and systemic viral dissemination are commonly found in severe COVID-19. This preprint study reports that immune cells (monocytes, CD4+ T cells, CD8+ T cells and B cells) are susceptible to SARS-CoV-2 infection. This was observed by in vitro infection of immune cells and by ex vivo detection of SARS-CoV-2 in peripheral blood mononuclear cells from patients with severe COVID-19. Post-mortem in situ analysis of lung tissues further confirmed the presence of infected immune cells in COVID-19. As monocytes and lymphocytes do not express ACE2, it remains to be seen whether the virus uses an alternative entry strategy and whether circulating infected immune cells contribute to viral spread and COVID-19 disease progression.

Competing interests

The authors declare no competing interests.

Contributor Information

Mariana Borsa, Email: covid19lit@medsci.ox.ac.uk.

Julie M. Mazet, Email: covid19lit@medsci.ox.ac.uk

References

Original article

  1. Pontelli MC, et al. Infection of human lymphomononuclear cells by SARS-CoV-2. bioRxiv. 2020 doi: 10.1101/2020.07.28.225912. [DOI] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES